Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome

Intensive Care Medicine

Volumn 42, Issue 3, 2016, Pages 333-341

  Ong, David S Y ^a   Spitoni, Cristian ^a,b   Klein Klouwenberg, Peter M C ^a   Verduyn Lunel, Frans M ^a   Frencken, Jos F ^a   Schultz, Marcus J ^c   van der Poll, Tom ^c   Kesecioglu, Jozef ^a   Bonten, Marc J M ^a   Cremer, Olaf L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

ARDS; Cytomegalovirus; Mortality; Reactivation; Viremia

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CAUSE OF DEATH; COHORT ANALYSIS; CYTOMEGALOVIRUS; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; VIRUS LOAD; VIRUS REACTIVATION; APACHE; CYTOMEGALOVIRUS INFECTION; EPIDEMIOLOGY; VIROLOGY;

AGED; APACHE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 84957945283     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-4071-z     Document Type: Article

References (39)

1. Gandhi MK, Khanna R (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4:725–738. doi:10.1016/S1473-3099(04)01202-2
2. Chiche L, Forel J-M, Roch A et al (2009) Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 37:1850–1857. doi:10.1097/CCM.0b013e31819ffea6
3. Chilet M, Aguilar G, Benet I et al (2010) Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol 82:1384–1391. doi:10.1002/jmv.21825
4. Coisel Y, Bousbia S, Forel J-M et al (2012) Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One 7:e51340. doi:10.1371/journal.pone.0051340
5. Heininger A, Haeberle H, Fischer I et al (2011) Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 15:R77. doi:10.1186/cc10069
6. Kalil AC, Florescu DF (2009) Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 37:2350–2358. doi:10.1097/CCM.0b013e3181a3aa43
7. Limaye AP, Kirby KA, Rubenfeld GD et al (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300:413–422. doi:10.1001/jama.300.4.413
8. Walton AH, Muenzer JT, Rasche D et al (2014) Reactivation of multiple viruses in patients with sepsis. PLoS One 9:e98819. doi:10.1371/journal.pone.0098819
9. Ziemann M, Sedemund-Adib B, Reiland P et al (2008) Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 36:3145–3150. doi:10.1097/CCM.0b013e31818f3fc4
10. Bordes J, Maslin J, Prunet B et al (2011) Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction: a prospective study. Burns 37:434–439. doi:10.1016/j.burns.2010.11.006
11. Heininger A, Haeberle H, Fischer I et al (2011) Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 15:R77. doi:10.1186/cc10069
12. von Müller L, Klemm A, Weiss M et al (2006) Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 12:1517–1522. doi:10.3201/eid1210.060411
13. Jaber S, Chanques G, Borry J et al (2005) Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 127:233–241. doi:10.1378/chest.127.1.233
14. Wolkewitz M, Cooper BS, Bonten MJM et al (2014) Interpreting and comparing risks in the presence of competing events. BMJ 349:g5060. doi:10.1136/bmj.g5060
15. Bravo D, Clari MA, Aguilar G et al (2014) Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients. J Med Virol 86:827–833. doi:10.1002/jmv.23838
16. Ong DSY, Klein Klouwenberg PMC, Verduyn Lunel FM et al (2015) Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome. Crit Care Med 43:394–400. doi:10.1097/CCM.0000000000000712
17. Cook CH, Zhang Y, Sedmak DD et al (2006) Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med 34:842–849
18. Papazian L, Doddoli C, Chetaille B et al (2007) A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 35:755–762. doi:10.1097/01.CCM.0000257325.88144.30
19. Ong DS, Spitoni C, Klein Klouwenberg P et al (2014) Cytomegalovirus reactivation in critically ill patients with acute respiratory distress syndrome (conference abstract ESICM 2014 Barcelona). Intensive Care Med 40:S127
20. Klein Klouwenberg PMC, Ong DSY, Bos LDJ et al (2013) Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 41:2373–2378. doi:10.1097/CCM.0b013e3182923712
21. Bernard GR, Artigas A, Brigham KL et al (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
22. van Doornum GJJ, Guldemeester J, Osterhaus ADME, Niesters HGM (2003) Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 41:576–580
23. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509. doi:10.1080/01621459.1999.10474144
24. Schumacher M, Wangler M, Wolkewitz M, Beyersmann J (2007) Attributable mortality due to nosocomial infections. A simple and useful application of multistate models. Methods Inf Med 46:595–600
25. Beyersmann J, Gastmeier P, Grundmann H et al (2006) Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 27:493–499. doi:10.1086/503375
26. Barnett AG, Beyersmann J, Allignol A et al (2011) The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 14:381–386. doi:10.1016/j.jval.2010.09.008
27. Robins JM, Hernán MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11:550–560
28. Bekaert M, Timsit J-F, Vansteelandt S et al (2011) Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 184:1133–1139. doi:10.1164/rccm.201105-0867OC
29. Forel J-M, Martin-Loeches I, Luyt C-E (2014) Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro. Intensive Care Med 40:1945–1949. doi:10.1007/s00134-014-3445-y
30. Chanques G, Jaber S (2014) Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con. Intensive Care Med 40:1950–1953. doi:10.1007/s00134-014-3521-3
31. Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874. doi:10.1038/nri3552
32. Campbell J, Trgovcich J, Kincaid M et al (2012) Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation. J Leukoc Biol 92:933–937. doi:10.1189/jlb.1211635
33. Bekaert M, Vansteelandt S, Mertens K (2010) Adjusting for time-varying confounding in the subdistribution analysis of a competing risk. Lifetime Data Anal 16:45–70. doi:10.1007/s10985-009-9130-8
34. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M (2009) Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 35:826–832. doi:10.1007/s00134-009-1423-6
35. Shintani AK, Girard TD, Eden SK et al (2009) Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. Crit Care Med 37:2939–2945. doi:10.1097/CCM.0b013e3181b7fbbb
36. Suissa S (2003) Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 168:49–53. doi:10.1164/rccm.200210-1231OC
37. Roa PL, Hill JA, Kirby KA et al (2015) Coreactivation of human herpesvirus 6 and cytomegalovirus is associated with worse clinical outcome in critically ill adults. Crit Care Med. doi:10.1097/CCM.0000000000000969
38. Blanquer J, Chilet M, Benet I et al (2011) Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients. J Med Virol 83:1966–1971. doi:10.1002/jmv.22202
39. Friedrichs I, Bingold T, Keppler OT et al (2013) Detection of herpesvirus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract? Med Microbiol Immunol 202:431–436. doi:10.1007/s00430-013-0306-1